<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01046942</url>
  </required_header>
  <id_info>
    <org_study_id>H-C-2007-0057</org_study_id>
    <nct_id>NCT01046942</nct_id>
  </id_info>
  <brief_title>ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery</brief_title>
  <acronym>TEG-CABG</acronym>
  <official_title>ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery(TEG-CABG Trial):Does Intensified Postoperative Antiplatelet Therapy in Preoperatively Identified Hypercoagulable Patients Improve Outcome After CABG Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether adding clopidogrel to aspirin after
      coronary bypass operation (CABG) improves graft patency, in patients that have preoperatively
      increased platelet activity(hypercoagulable) and therefore greater risk of graft occlusion(
      thrombosis).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Graft patency after CABG is reported to 80-90% worldwide 1 year following surgery. In the
      immediate period after surgery, and the following month, graft occlusion mainly occurs due to
      thrombosis.

      Patients with platelet hyperreactivity have increased risk of thromboembolic events,
      including graft occlusion, myocardial infarction and stroke. Therefore intensifying the
      antiplatelet therapy in these patients, must be anticipated to have beneficial effects.

      Hypercoagulable patients are identified with thrombelastography(TEG) as having a Maximal
      Amplitude(MA)&gt;69, thereafter randomized to either clopidogrel(3months) and aspirin or aspirin
      alone. At 3 months postoperative after surgery the coronary graft patency is assessed with
      Multislice CT scan.

      Pre- and postoperatively, and then again at 3month followup, TEG and multiplate aggregometry
      are performed to assess platelet reactivity and resistance to aspirin and clopidogrel.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2008</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Graft patency at 3 months</measure>
    <time_frame>3 months</time_frame>
    <description>Graft patency of Saphenous vein grafts will be significantly higher in TEG-Hypercoagulable patients on clopidogrel+aspirin vs. aspirin alone.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of other thromboembolic events( e.g. myocardial infarction,stroke, pulmonary embolus etc.)and cardiovascular death</measure>
    <time_frame>3 months</time_frame>
    <description>In the TEG-Hypercoagulable intervention group (clopidogrel+aspirin) we expect significantly lower rates, of other thromboembolic events (e.g. myocardial infarction,stroke, pulmonary embolism etc) and cardiovascular death, compared to TEG-Hypercoagulable patients on aspirin monotherapy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing coagulation profile pre- and postoperatively, including aspirin and clopidogrel resistance</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Graft Patency</condition>
  <condition>Coronary Artery Bypass Grafting Surgery</condition>
  <condition>Hypercoagulability</condition>
  <condition>Thrombosis</condition>
  <arm_group>
    <arm_group_label>Clopidogrel+Aspirin, hypercoagulabel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspirin,hypercoagulabel control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clopidogrel+acetylsalicylic acid</intervention_name>
    <description>loading dose clopidogrel 300mg on second postoperative day. Thereafter 75mg clopidogrel daily for 3 months Aspirin 75mg daily, started within 24 hours after surgery</description>
    <arm_group_label>Clopidogrel+Aspirin, hypercoagulabel</arm_group_label>
    <other_name>Plavix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>acetylsalicylic acid</intervention_name>
    <description>aspirin 75 mg daily, started 6-24 hours after surgery</description>
    <arm_group_label>Aspirin,hypercoagulabel control</arm_group_label>
    <other_name>Aspirin</other_name>
    <other_name>Magnyl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective/subacute multivessel CABG

          -  Isolated CABG procedure, no concomitant surgery

          -  age &gt; 18 years

          -  Able to give informed consent

        Exclusion Criteria:

          -  Myocardial infarction &lt;48h of surgery

          -  Prior CABG surgery within 1 month

          -  Cardiac Shock within 48h of surgery

          -  Atrial fibrillation

          -  Anticoagulation therapy with VKA

          -  ICH/TCI within 30 days

          -  Prior peptic ulcer· Platelet count &lt; 150 E9

          -  Ongoing bleeding

          -  Known platelet disease

          -  Allergic to aspirin or clopidogrel

          -  Liver disease with elevated ALAT/ASAT&gt; 1,5x normal

          -  Creatinine&gt; 0,120mmol/l

          -  Contrast allergy

          -  Alcohol or narcotics abuse

          -  Pregnancy

          -  Not able to give informed consent

          -  Geographically not available for follow up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sulman Rafiq, MD</last_name>
    <role>Study Director</role>
    <affiliation>Dept. of Cardiothoracic Surgery, Rigshospitalet, Copenhagen University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel Steinbrüchel, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Cardiothoracic Surgery, Rigshospitalet, Copenhagen University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pär Johansson, cons. MD,MPA</last_name>
    <role>Study Director</role>
    <affiliation>Blood Bank, Rigshospitalet, Copenhagen University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Klaus Kofoed, cons.MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dep. of Cardiology, Rigshospitalet,Copenhagen University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mette Zacho, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Radiology, Rigshospitalet, Copenhagen University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Trine Stissing, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Blood Bank, Rigshospitalet, Copenhagen University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sulman Rafiq, MD</last_name>
    <phone>(0045) 35458728</phone>
    <email>sulman_raf@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniel Steinbrüchel, Professor</last_name>
    <phone>(0045) 35458016</phone>
    <email>daniel.steinbrüchel@rh.hosp.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dep. of cardiothoracic surgery, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <state>Kbh</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sulman Rafiq, MD</last_name>
      <phone>(0045) 35458728</phone>
      <email>sulman_raf@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2010</study_first_submitted>
  <study_first_submitted_qc>January 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2010</study_first_posted>
  <last_update_submitted>September 23, 2013</last_update_submitted>
  <last_update_submitted_qc>September 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Sulman Rafiq</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Saphenous vein</keyword>
  <keyword>Antiplatelet therapy</keyword>
  <keyword>Hypercoagulable</keyword>
  <keyword>Clopidogrel resistance</keyword>
  <keyword>Aspirin resistance</keyword>
  <keyword>Clopidogrel</keyword>
  <keyword>Aspirin</keyword>
  <keyword>Saphenous vein graft disease</keyword>
  <keyword>TEG</keyword>
  <keyword>Thrombelastography</keyword>
  <keyword>Multiplate aggregometry</keyword>
  <keyword>Multislice CT</keyword>
  <keyword>Coronary artery bypass graft surgery</keyword>
  <keyword>coagulation status</keyword>
  <keyword>graft patency</keyword>
  <keyword>CABG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Thrombophilia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Ticlopidine</mesh_term>
    <mesh_term>Clopidogrel</mesh_term>
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

